MILLIGAN JOHN F 1191589 Data last updated 2024-05-11 06:58:14 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.


Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-05-25 2023-05-23 2023-05-23 4 Milligan John F DIRECTOR acq 33750.0 100.0 10.15 17.98 Direct Stock Option (Right To Buy) 4D MOLECULAR THERAPEUTICS, INC.

code_A

code  A
33750.0 33.26 (FMDT)
2023-05-26 2023-05-24 2023-05-24 4 Milligan John F DIRECTOR acq 25775.0 100.0 1.03 11.94 Direct Stock Option (Right To Buy) PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

code_A

code  A
25775.0 249.89 (PACB)

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)